Latest Updates

The event will discuss on how pharma manufacturers should efficiently implement excellence initiatives

Signs deal for exclusive marketing and distribution of the only US FDA approved inhaled insulin

To treat hypertension, heart failure (NYHA class II – IV) and reduces cardiovascular mortality in clinically stable patients

For the treatment of platinum-sensitive relapsed ovarian cancer

Hospital business of Apotex will not form part of the merged entity and will be retained by Apotex

Products are being developed for cognitive disorders with high unmet medical need and with huge market potential globally

Etanercept (YLB113) is indicated for moderate to severe Rheumatoid Arthritis (RA) and Juvenile Idiopathic Arthritis

It is used for the treatment of schizophrenia and bipolar disease

CDSCO announces one year extension of WHO-GMP certifications

It will be the largest overseas acquisition by a Japanese company